Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

[Clinical implication of minimal residual disease monitoring by 10-color flow cytometry in multiple myeloma].

Yao WQ, Zhu MQ, Yan LZ, Jin S, Shang JJ, Yao Y, Yan S, Liu Y, Wu DP, Fu CC.

Zhonghua Xue Ye Xue Za Zhi. 2019 Sep 14;40(9):720-725. doi: 10.3760/cma.j.issn.0253-2727.2019.09.002. Chinese.

PMID:
31648471
2.

[Allogeneic CAR-T for treatment of relapsed and/or refractory multiple myeloma: four cases report and literatures review].

Yan LZ, Shang JJ, Shi XL, Qu S, Kang LQ, Xu N, Chang WR, Yu L, Wu DP, Fu CC.

Zhonghua Xue Ye Xue Za Zhi. 2019 Aug 14;40(8):650-655. doi: 10.3760/cma.j.issn.0253-2727.2019.08.005. Review. Chinese.

PMID:
31495131
3.

LncRNA XIST facilitates cell growth, migration and invasion via modulating H3 histone methylation of DKK1 in neuroblastoma.

Zhang J, Li WY, Yang Y, Yan LZ, Zhang SY, He J, Wang JX.

Cell Cycle. 2019 Aug;18(16):1882-1892. doi: 10.1080/15384101.2019.1632134. Epub 2019 Jul 7.

PMID:
31208278
4.

[Expression level and clinical significance of MEF2C gene in adult acute myeloid leukemia].

Yan LZ, Chen SN, He XF, Zhao Y, Zhang XY, Wu LL, Ping NN, Xu XY, Sun AN, Qiu HY, Tang XW, Han Y, Fu CC, Jin ZM, Miao M, Wu DP.

Zhonghua Xue Ye Xue Za Zhi. 2018 Aug 14;39(8):682-685. doi: 10.3760/cma.j.issn.0253-2727.2018.08.015. Chinese. No abstract available.

PMID:
30180473
5.

The opposite roles of PAS-5 and Galectin-1 in immune response during the early infection of Angiostrongylus cantonensis.

Yan LZ, Shi XM, Zu YW, Shen YY, Chen XX, Zhao MJ, Li XP, Yan BL, Huang HC.

Parasit Vectors. 2018 May 29;11(1):318. doi: 10.1186/s13071-018-2894-5.

6.

Association of hypertension and treatment outcomes in advanced stage non-small cell lung cancer patients treated with bevacizumab or non-bevacizumab containing regimens.

Yan LZ, Dressler EV, Adams VR.

J Oncol Pharm Pract. 2018 Apr;24(3):209-217. doi: 10.1177/1078155217690921. Epub 2017 Feb 21.

PMID:
29284349
7.

Development of a paper-based microfluidic analytical device by a more facile hydrophobic substrate generation strategy.

Xue YY, Zhang WT, Zhang MY, Liu LZ, Zhu WX, Yan LZ, Wang J, Wang YR, Wang JL, Zhang DH.

Anal Biochem. 2017 May 15;525:100-106. doi: 10.1016/j.ab.2017.03.001. Epub 2017 Mar 3.

PMID:
28263739
8.

[Cloning of galectin-1 gene of Angiostrongylus cantonensis and testing the agglutination property of the galectin-1 protein].

Li XP, Zhao MJ, Shi XM, Yan LZ, Yan BL, Huang HC.

Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2017 Feb;35(1):48-52. Chinese.

PMID:
30133242
9.

Long-term propagation of tree shrew spermatogonial stem cells in culture and successful generation of transgenic offspring.

Li CH, Yan LZ, Ban WZ, Tu Q, Wu Y, Wang L, Bi R, Ji S, Ma YH, Nie WH, Lv LB, Yao YG, Zhao XD, Zheng P.

Cell Res. 2017 Feb;27(2):241-252. doi: 10.1038/cr.2016.156. Epub 2016 Dec 23.

10.

Early embryonic development and transplantation in tree shrews.

Yan LZ, Sun B, Lyu LB, Ma YH, Chen JQ, Lin Q, Zheng P, Zhao XD.

Dongwuxue Yanjiu. 2016 Jul 18;37(4):252-8. doi: 10.13918/j.issn.2095-8137.2016.4.252.

11.

[Efficacy and prognosis of PAD combination therapy for fifty-six previously untreated patients with multiple myeloma].

Yan S, Fu CC, Ma L, Zhou J, Jin S, Yan LZ, Zhu XM, Wang PF, Xu Y, Wu DP.

Zhonghua Xue Ye Xue Za Zhi. 2016 Jun 14;37(6):520-2. doi: 10.3760/cma.j.issn.0253-2727.2016.06.016. Chinese. No abstract available.

PMID:
27431080
12.

Outcomes of hospitalized neutropenic oncology patients with Pseudomonas aeruginosa bloodstream infections: focus on oral fluoroquinolone conversion.

Yan LZ, Herrington JD.

J Oncol Pharm Pract. 2016 Aug;22(4):584-90. doi: 10.1177/1078155215591389. Epub 2015 Jul 7.

PMID:
26156260
13.

Hydrophilic/hydrophobic characters of antimicrobial peptides derived from animals and their effects on multidrug resistant clinical isolates.

Liu CB, Shan B, Bai HM, Tang J, Yan LZ, Ma YB.

Dongwuxue Yanjiu. 2015 Jan 18;36(1):41-7. doi: 10.13918/j.issn.2095-8137.2015.1.41.

14.

Identification of LY2510924, a novel cyclic peptide CXCR4 antagonist that exhibits antitumor activities in solid tumor and breast cancer metastatic models.

Peng SB, Zhang X, Paul D, Kays LM, Gough W, Stewart J, Uhlik MT, Chen Q, Hui YH, Zamek-Gliszczynski MJ, Wijsman JA, Credille KM, Yan LZ.

Mol Cancer Ther. 2015 Feb;14(2):480-90. doi: 10.1158/1535-7163.MCT-14-0850. Epub 2014 Dec 12.

15.

[Clinical and laboratorial analysis for 15 adult cases of mixed phenotypic acute leukemia with Ph chromosome and/or positive BCR-ABL].

Yan LZ, Chen SN, Ping NN, Wang QR, Liu H, Ding ZX, Zhu MQ, Liang JY, Liu DD, Cen JN, Pan JL, Qiu HY, Sun AN, Wu DP.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013 Oct;21(5):1116-20. doi: 10.7534/j.issn.1009-2137.2013.05.006. Chinese.

PMID:
24156417
16.

Bacterial and fungal diversity in the starter production process of Fen liquor, a traditional Chinese liquor.

Li XR, Ma EB, Yan LZ, Meng H, Du XW, Quan ZX.

J Microbiol. 2013 Aug;51(4):430-8. doi: 10.1007/s12275-013-2640-9. Epub 2013 Aug 30.

PMID:
23990293
17.

[Levonorgestrel-releasing intrauterine system and combined oral contraceptives as conservative treatments for recurrent ovarian endometriosis: a comparative clinical study].

Xu XW, Wang LD, Zhu XQ, Yan LZ, Guan YT, Zhu SC, Hu Y.

Zhonghua Yi Xue Za Zhi. 2011 Apr 19;91(15):1047-50. Chinese.

PMID:
21609640
18.

Discovery of potent, cyclic calcitonin gene-related peptide receptor antagonists.

Yan LZ, Johnson KW, Rothstein E, Flora D, Edwards P, Li B, Li J, Lynch R, Vaughn R, Clemens-Smith A, McCarty D, Chow C, McKnight KL, Lu J, Nisenbaum ES, Mayer JP.

J Pept Sci. 2011 May;17(5):383-6. doi: 10.1002/psc.1358. Epub 2011 Mar 15.

PMID:
21412957
19.

Bacterial and fungal diversity in the traditional Chinese liquor fermentation process.

Li XR, Ma EB, Yan LZ, Meng H, Du XW, Zhang SW, Quan ZX.

Int J Food Microbiol. 2011 Mar 15;146(1):31-7. doi: 10.1016/j.ijfoodmicro.2011.01.030. Epub 2011 Feb 2.

PMID:
21377228
20.

Rapid and recurrent neutrophil mobilization regulated by T134, a CXCR4 peptide antagonist.

Iyer CV, Evans RJ, Lou Q, Lin D, Wang J, Kohn W, Yan LZ, Pulley S, Peng SB.

Exp Hematol. 2008 Sep;36(9):1098-109. doi: 10.1016/j.exphem.2008.03.021. Epub 2008 May 20.

PMID:
18495324
21.

[A study of NPM1 and FLT3 gene mutations in acute myeloid leukemia].

Wu DP, Yan LZ, Yang L, Chen SN, Wu XJ, Liang JY.

Zhonghua Nei Ke Za Zhi. 2007 Nov;46(11):907-10. Chinese.

PMID:
18261272
22.

[Analysis of NPM1 gene mutations in acute myeloid leukemia].

Yan LZ, Chen SN, Liang JY, Feng YF, Cen JN, He J, Chang WR, Zhu ZL, Pan JL, Wu YF, Xue YQ, Wu DP.

Zhonghua Xue Ye Xue Za Zhi. 2007 May;28(5):289-93. Chinese.

PMID:
17877154
23.

Melanocortin-4 receptor agonists for the treatment of obesity.

Emmerson PJ, Fisher MJ, Yan LZ, Mayer JP.

Curr Top Med Chem. 2007;7(11):1121-30. Review.

PMID:
17584132
24.

Structure-activity relationships of beta-MSH derived melanocortin-4 receptor peptide agonists.

Yan LZ, Hsiung HM, Heiman ML, Gadski RA, Emmerson PJ, Hertel J, Flora D, Edwards P, Smiley D, Zhang L, Husain S, Kahl SD, DiMarchi RD, Mayer JP.

Curr Top Med Chem. 2007;7(11):1052-67. Review.

PMID:
17584126
25.

A novel and selective beta-melanocyte-stimulating hormone-derived peptide agonist for melanocortin 4 receptor potently decreased food intake and body weight gain in diet-induced obese rats.

Hsiung HM, Hertel J, Zhang XY, Smith DP, Smiley DL, Heiman ML, Yang DD, Husain S, Mayer JP, Zhang L, Mo H, Yan LZ.

Endocrinology. 2005 Dec;146(12):5257-66. Epub 2005 Sep 15.

PMID:
16166226
26.

Potent and selective MC-4 receptor agonists based on a novel disulfide scaffold.

Yan LZ, Flora D, Edwards P, Smiley DL, Emmerson PJ, Hsiung HM, Gadski R, Hertel J, Heiman ML, Husain S, O'Brien TP, Kahl SD, Zhang L, Dimarchi RD, Mayer JP.

Bioorg Med Chem Lett. 2005 Oct 15;15(20):4611-4.

PMID:
16105738
27.

Potent peptide agonists for human melanocortin 3 and 4 receptors derived from enzymatic cleavages of human beta-MSH(5-22) by dipeptidyl peptidase I and dipeptidyl peptidase IV.

Hsiung HM, Smiley DL, Zhang XY, Zhang L, Yan LZ, Craft L, Heiman ML, Smith DP.

Peptides. 2005 Oct;26(10):1988-96.

PMID:
15985311
28.

[Generation of transgenic mice for hygromycin and neomycin resistance genes and studies on transgene expression].

Dang SY, Ma SK, Sun X, Yan LZ, Wang ZG.

Sheng Wu Gong Cheng Xue Bao. 2005 Jan;21(1):159-62. Chinese.

PMID:
15859348
29.

Discovery of a beta-MSH-derived MC-4R selective agonist.

Mayer JP, Hsiung HM, Flora DB, Edwards P, Smith DP, Zhang XY, Gadski RA, Heiman ML, Hertel JL, Emmerson PJ, Husain S, O'brien TP, Kahl SD, Smiley DL, Zhang L, Dimarchi RD, Yan LZ.

J Med Chem. 2005 May 5;48(9):3095-8.

PMID:
15857110
30.

Detection and control of aspartimide formation in the synthesis of cyclic peptides.

Flora D, Mo H, Mayer JP, Khan MA, Yan LZ.

Bioorg Med Chem Lett. 2005 Feb 15;15(4):1065-8.

PMID:
15686913
31.

Use of trichloroacetimidate linker in solid-phase Peptide synthesis.

Yan LZ, Mayer JP.

J Org Chem. 2003 Feb 7;68(3):1161-2.

PMID:
12558452
33.
34.

Analogues of bacteriocins: antimicrobial specificity and interactions of leucocin A with its enantiomer, carnobacteriocin B2, and truncated derivatives.

Yan LZ, Gibbs AC, Stiles ME, Wishart DS, Vederas JC.

J Med Chem. 2000 Nov 30;43(24):4579-81. No abstract available.

PMID:
11101349
35.
36.

Solution structure of carnobacteriocin B2 and implications for structure-activity relationships among type IIa bacteriocins from lactic acid bacteria.

Wang Y, Henz ME, Gallagher NL, Chai S, Gibbs AC, Yan LZ, Stiles ME, Wishart DS, Vederas JC.

Biochemistry. 1999 Nov 23;38(47):15438-47.

PMID:
10569926

Supplemental Content

Support Center